Purdue Pharma officially ceased operations on May 1, 2026, transitioning its remaining assets into a new nonprofit entity, Knoa Pharma. Simultaneously, the Mississippi Attorney General confirmed the legal effectiveness of the $7.4 billion settlement against the Sackler family, marking the formal conclusion of a bankruptcy saga that has defined corporate accountability discourse for years.
On the podcast On with Kara Swisher, host Kara Swisher revisited the deep-seated anger surrounding the company's legacy. Referencing the work of journalist Patrick Radden Keefe, she noted her lingering fury regarding the firm's history, stating, "I am still incandescent after reading that book, I have to say. Not incandescent. Someone pointed out I wasn't using... I was furious. Um, their company, Purdue Pharma, re- finally received its sentencing."
While the bankruptcy is now closed, the podcast commentary remains focused on the moral weight of the settlement rather than the administrative end of the firm. There is little debate among critics regarding the company's culpability, but the shift toward Knoa Pharma as a nonprofit will likely trigger new scrutiny regarding whether a state-appointed board can effectively pivot the company's infrastructure toward addressing the opioid crisis. Expect the conversation to move toward the efficacy of these settlement payouts in the coming months.
